Carregant...
Blinatumomab: Enlisting serial killer T cells in the war against hematologic malignanciess
INTRODUCTION: The approval of blinatumomab signals the long awaited arrival of immunotherapy for acute lymphoblastic leukemia (ALL). Previous options for relapsed or refractory disease were restricted to combination cytotoxic chemotherapy with limited efficacy and significant toxicity. Through an in...
Guardat en:
| Publicat a: | Expert Opin Biol Ther |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2015
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4994468/ https://ncbi.nlm.nih.gov/pubmed/25985814 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1517/14712598.2015.1041912 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|